Skip to main content
. 2018 May 23;37(36):4903–4920. doi: 10.1038/s41388-018-0341-x

Table 1.

Molecular alterations that promote EMT

Molecular alterations Signalling pathways References
ACh M3R/AMPK/MACC1 [155]
ACK1 AKT/POU2F1/ECD [156, 157]
AEP AKT/MARK [158]
CCR7 TGFβ/ERK/PI3K/Snail [159161]
CUL4A Hippo [162]
CUL4B PI3K/AKT [163]
ECM1 ITGB4/FAK/SOX2/HIF-1α [164]
EGF Arf6-ERK [22, 165167]
EphA2 WNT/β-Catenin [38, 168, 169]
FOXK1 C-jun [170]
FOXM1 [171]
FOXO3a [172]
HIF-1α Snail [173]
HOTAIR HGF/C­Met/Snail [174]
IFITM2 IGF1/IGF1R/STAT3 [175]
IL-6 JAK2/STAT3 [176]
IL-17 STAT3 [177]
JMJD2B WNT/β-Catenin [37, 178, 179]
MICAL2 [180]
Orai1, STIM1 [181]
Rab11-FIP2 [182]
RBP2 TGF­β1/Smad3 [183]
RhoGDI2 NFκB/Snail [18, 184, 185]
SALL4 [186]
SENP3 [187]
Shh PI3K/AKT [188]
SPOCK1 [17, 189, 190]
SRF [29, 191]
TBL1XR1 β­catenin/MMP7/EGFR/ERK [192]
TMPRSS4 [193]
ZIPK AKT/IκB/NF­κB [194]
miR-21 [36]
miR-130 TGF­β [195]
miR-181a-5p MAKP [196]
miR-181b TGF­β/SMAD2/3/4 [197]
miR-363 [198]
miR-421 [199]
miR-544a WNT [31]
miR-940 [200]